Since 2015, the subcommittee has provided you with $1.5 million with the direction that it be transferred to specifically focus on oversight issues related to FDA.

more than 60 percent of drug manufacturers for the U.S. market are located overseas, and 80 percent of active pharmaceutical ingredients are manufactured overseas

How have these funds allowed your office to focus more on FDA, and what activities have you been able to support that otherwise might not have been done?

Well, I'm given to understand that with the trade mitigation payments that the administration has made over the last year, that a large amount of that money has gone to alternative lenders for repayment of their loans.

The annual report notes that today there are high capital demands of agriculture and new entrants require affordable and dependable credit.

I would like to look closely at the financial relationship between the USDA and the Farm Credit system as we begin to develop this year's appropriations bill.

It is important that we unpack this as well.

I recognize that we have had a number of good years, and an increase in bankruptcy from a very low level. It is still a problem, but it has to be put in context.

We need to know if there are any warning signs on the horizon, and to know if Congress needs to act in preparation for any threat coming to the farm economy.

We look forward to working with you as you continue the fiscal year 2021 appropriations process.

There have been some positive developments, such as the signing of the phase one of the China Trade Deal.

It appears as if they end up being delayed unnecessarily in getting the results that they need to help their people.